1Cohen G,H(o)rl WH. Resistin as a cardiovascular and atherosclerotic risk factor and uremic toxin[J].Seminars in Dialysis,2009,(04):373-377.doi:10.1111/j.1525-139X.2009.00583.x.
5Reilly MP,Lehrke M,Wolfe ML. Resistin is an inflammatory marker of atherosclerosis in humans[J].Circulation,2005,(07):932-939.
6Karbowska A,Boratynska M,Kusztal M. Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients[J].Transplantation Proceedings,2009,(08):3052-3055.doi:10.1016/j.transproceed.2009.07.080.
7Boratynska M,Karbowska A,Klinger M. The effect of hyperuricemia on endothelial biomarkers and renal function in kidney allograft recipients[J].Transplantation Proceedings,2010,(10):4074-4077.doi:10.1016/j.transproceed.2010.09.069.
8Filippidis G,Liakopoulos V,Mertens PR. Resistin serum levels are increased but not correlated with insulin resistance in chronic hemodialysis patients[J].Blood Purification,2005,(06):421-428.doi:10.1159/000088017.
9Malyszko J,Malyszko JS,Kozminski P. Elevated resistin is related to inflammation and residual renal function in haemodialysed patients[J].Nephrology,2007,(03):246-253.
10Allon M, Depner TA, Radeva M, et al. Impact of dialysis dose and membrane on infection - related hospitalization and death: Results of the HEMO Study. J Am Soc Nephrol ,2003 ,14 :1863 -1870.
